This site is intended for healthcare professionals only
LoginRegister
Cancer MedTech Gets Clarity: CDSCO Releases Final Oncology Device Risk Classification ListMedical devices of all four categories will be brought under regulation by October 1: DCGI
Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome CaseModerna announces global regulatory submissions for respiratory syncytial virus vaccine
Biocon unveils Liraglutide for diabetes, obesity in NetherlandsBiocon Biologics takes over biosimilars business from Viatris in over 70 countries
NPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin, DetailsNPPA fixes Ceiling Price of Dabigatran capsules
Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, EuropeDr Reddys Labs step down arm to establish bio-manufacturing facility in Hyderabad
Budget Quotes - Mankind Pharma, Bharat Serum and Vaccines & Park Medi WorldMankind Pharma success boosts hopes of more consumer IPOs in India
US District Court rules in favour of Orexo in patent litigation against Sun Pharma on Zubsolv patentUS District Court rules in favour of Orexo in patent litigation against Sun Pharma on Zubsolv patent
Strides Pharma Science biologics arm to divest Unit 3 multi modal facility to Syngene International for Rs 702 croreStrides Pharma Science biologics arm to divest Unit 3 multi modal facility to Syngene International...
positive phase 3 trialBreast cancer biosimilar product meets primary endpoint in Phase 3 clinical trial: Aurobindo Pharma
Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, EuropeDr. Reddy's Gets CDSCO Panel Nod To Study Tegoprazan for gastrointestinal diseases
Lupin Dolutegravir Tablets for Oral Suspension gets tentative USFDA nod for HIV/AIDSLupin Dolutegravir Tablets for Oral Suspension gets tentative USFDA nod for HIV/AIDS
Zydus Lifesciences wins USFDA approval for Oxcarbazepine tablets to treat seizure disordersZydus Lifesciences wins USFDA approval for Oxcarbazepine tablets to treat seizure disorders
X